Q4 2025 Holdings
Filed 2026-02-17 | 21 holdings | $318.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $41.7M | 4,056,379 | 13.1% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $36.0M | 5,869,091 | 11.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $27.1M | 1,029,298 | 8.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $22.9M | 736,595 | 7.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.1M | 797,600 | 7.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $20.1M | 5,405,404 | 6.3% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $19.2M | 1,050,000 | 6.0% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $16.7M | 950,011 | 5.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $14.5M | 580,945 | 4.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.5M | 497,270 | 4.2% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $12.7M | 606,660 | 4.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $11.9M | 772,477 | 3.7% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $10.1M | 2,353,304 | 3.2% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $8.8M | 387,500 | 2.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.3M | 738,972 | 2.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.3M | 1,369,782 | 2.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $7.3M | 572,665 | 2.3% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $7.3M | 9,681,763 | 2.3% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $5.3M | 3,947,913 | 1.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.9M | 476,200 | 0.9% |
| Rallybio Corp | COM | 75120L100 | $2.5M | 3,630,724 | 0.8% |